menu
    • menu

    Company profile for D&D Pharmatech

    NEW Drugs in Dev: 1
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indi...
    D&D Pharmatech is a clinical-stage global biotech company that funds the development of revolutionary medicines through disease-specific subsidiary companies founded and guided by top-tier medical research faculty. This corporate structure creates a unique opportunity to accelerate translation of cutting-edge research into lifesaving therapeutic products for patients. The company’s product pipeline focuses on a range of indications including neurodegenerative and fibrotic diseases as well as application of big data in CNS drug research and diagnostics.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    D&D Pharmatechkorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    5th Floor, I&C Building, 24, Pangyo-ro 255 beon-gil, Bundang-gu, Seongnam-si, ...
    Telephone
    Telephone
    +82-31-8019-7771
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.ddpharmatech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ddpharmatech
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    D&D Pharmatech Completes Enrollment for DD01 Phase 2 Trial in MASH
    D&D Pharmatech Completes Enrollment for DD01 Phase 2 Trial in MASH

    03 Feb 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250203437606/en

    BUSINESSWIRE
    03 Feb 2025
    Share Share
    D&D Pharmatech Initiates Phase 2 Trial For Obesity Treatment DD01
    D&D Pharmatech Initiates Phase 2 Trial For Obesity Treatment DD01

    21 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240821336927/en

    BUSINESSWIRE
    21 Aug 2024
    Share Share
    D&D Granted Fast Track Designation from FDA for DD01 for the NASH/MASH
    D&D Granted Fast Track Designation from FDA for DD01 for the NASH/MASH

    02 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240402237132/en

    BUSINESSWIRE
    02 Apr 2024
    Share Share
    D&D Pharmatech Announces Rapid, Clinically Significant Reductions in Liver Fat
    D&D Pharmatech Announces Rapid, Clinically Significant Reductions in Liver Fat

    02 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230502005057/en

    BUSINESSWIRE
    02 May 2023
    Share Share
    Neuraly points to younger patients as Parkinson's bet fails
    Neuraly points to younger patients as Parkinson's bet fails

    27 Mar 2023

    // Annalee Armstrong FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/neuraly-points-younger-patients-hope-parkinsons-bet-fails-phase-2

    Annalee Armstrong FIERCE BIOTECH
    27 Mar 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search